Amsterdam, Netherlands

Niels Van De Donk

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • Amsterdam, NL (2020)
  • De Boelelaan, NL (2021)
  • De Boelalaan, NL (2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Niels Van De Donk: Innovator in Cancer Treatment

Introduction

Niels Van De Donk is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative methods and research. With a total of four patents to his name, he is recognized for his dedication to enhancing therapeutic approaches in oncology.

Latest Patents

Niels Van De Donk's latest patents focus on methods of treating cancers and enhancing the efficacy of T cell redirecting therapeutics. These patents disclose novel techniques aimed at improving treatment outcomes for cancer patients. His work in this area is crucial for advancing therapeutic strategies and providing new hope for those affected by cancer.

Career Highlights

Throughout his career, Niels has worked with notable organizations, including Janssen Biotech, Inc. and Stichting Vumc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Niels has collaborated with esteemed colleagues such as Henk Lokhorst and Tuna Mutis. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the pursuit of effective cancer treatments.

Conclusion

Niels Van De Donk is a dedicated inventor whose work in cancer treatment is paving the way for new therapeutic methods. His contributions to the field are invaluable and continue to inspire advancements in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…